Refining Patient Reported Outcomes
Brian Tiplady, Ph.D.
– Senior Scientific Consultant 
Dr. Tiplady was trained as a Neuroscientist, working first in academic research, then with the Swedish pharmaceutical company Astra (later part of AstraZeneca). He was responsible for projects in central nervous system clinical research, first in depression, and then in senile dementia. In Dr. Tiplady’s 27 years in the pharmaceutical industry, he has been involved with all stages of the clinical trial process, from being an investigator in human pharmacology studies, through monitoring, project management, data handling and IT, statistical analysis and reporting. Starting in 1993, he became increasingly involved with electronic diaries and questionnaires, having set up some of the early evaluation studies which showed high patient acceptability of these systems. He supported a variety of in-house projects at AstraZeneca using handheld diaries, and worked with strategic and logistic issues involved in effectively using electronic data collection of patient reported outcomes, and in evaluating the benefits obtained.
Additional information on Brian’s work can be found at www.penscreen.com
Where to find Brian:
Original Date: Tuesday, August 18, 2009 - 10:00 a.m. ET
Choosing an ePRO Modality For Your Clinical Trial Webinar
Do you plan to incorporate patient reported outcome (PRO) data into an upcoming clinical program? While many of your colleagues might understand the benefits of collecting PRO data electronically, few sponsors view the chosen technology systems from the perspective of patients who enroll in clinical trials. Despite the fact that device-based ePRO and interactive voice response (IVR) ePRO are acknowledged as the dominant methods for electronic PRO collection, sponsors sometimes struggle with determining which modality is best suited to capture their PRO data.
This webinar will discuss a newly developed ePRO modality decision tool that will guide you in selecting the most appropriate ePRO system based on your study parameters. The pros and cons of the various ePRO modalities will be discussed with an emphasis on how important patient-specific factors influence responses in an electronic format.
As an added bonus, everyone who attends the webinar will receive an electronic copy of the newly published white paper, "PDA or IVR-based Patient-Reported Outcome Systems: A decision tool industry should consider when deciding on an electronic PRO modality."
Presenters
James Pierce, Ph.D.
Scientific Advisor
Perceptive Informatics
Brian Tiplady, Ph.D.
Senior Scientific Consultant
PRO Consulting
invivodata